Lutein
•Last Updated: September 28 2022
Lutein, as well as the related zeaxanthin, are carotenoid structures similar to pre-vitamin A (β-carotene) and involved in eye health. A dietary component of eggs, lutein appears to be effective for this claim and a general antioxidant.
Lutein is most often used for
Last Updated: September 28 2022
Lutein is a carotenoid structure similar to Zeaxanthin, and the two are components of many food products such as egg yolks and paprika. Lutein may bioaccumulate in the eyes where it is thought to reduce oxidative stress.
Research feed
1.^Goodrow EF, Wilson TA, Houde SC, Vishwanathan R, Scollin PA, Handelman G, Nicolosi RJConsumption of one egg per day increases serum lutein and zeaxanthin concentrations in older adults without altering serum lipid and lipoprotein cholesterol concentrationsJ Nutr.(2006 Oct)
2.^Handelman GJ, Nightingale ZD, Lichtenstein AH, Schaefer EJ, Blumberg JBLutein and zeaxanthin concentrations in plasma after dietary supplementation with egg yolkAm J Clin Nutr.(1999 Aug)
3.^Wenzel AJ, Gerweck C, Barbato D, Nicolosi RJ, Handelman GJ, Curran-Celentano JA 12-wk egg intervention increases serum zeaxanthin and macular pigment optical density in womenJ Nutr.(2006 Oct)
4.^Hammond BR Jr, Johnson EJ, Russell RM, Krinsky NI, Yeum KJ, Edwards RB, Snodderly DMDietary modification of human macular pigment densityInvest Ophthalmol Vis Sci.(1997 Aug)
5.^Solomons NW, Bulux JPlant sources of vitamin A and human nutrition revisited: recent evidence from developing countriesNutr Rev.(1994 Feb)
6.^Stahl W, Sies HUptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humansJ Nutr.(1992 Nov)
7.^Chung HY, Rasmussen HM, Johnson EJLutein bioavailability is higher from lutein-enriched eggs than from supplements and spinach in menJ Nutr.(2004 Aug)
8.^Vishwanathan R, Goodrow-Kotyla EF, Wooten BR, Wilson TA, Nicolosi RJConsumption of 2 and 4 egg yolks/d for 5 wk increases macular pigment concentrations in older adults with low macular pigment taking cholesterol-lowering statinsAm J Clin Nutr.(2009 Nov)
9.^Surai PF, MacPherson A, Speake BK, Sparks NHDesigner egg evaluation in a controlled trialEur J Clin Nutr.(2000 Apr)
10.^Borel P, Grolier P, Mekki N, Boirie Y, Rochette Y, Le Roy B, Alexandre-Gouabau MC, Lairon D, Azais-Braesco VLow and high responders to pharmacological doses of beta-carotene: proportion in the population, mechanisms involved and consequences on beta-carotene metabolismJ Lipid Res.(1998 Nov)
11.^Johnson EJ, Qin J, Krinsky NI, Russell RMIngestion by men of a combined dose of beta-carotene and lycopene does not affect the absorption of beta-carotene but improves that of lycopeneJ Nutr.(1997 Sep)
12.^Henderson CT, Mobarhan S, Bowen P, Stacewicz-Sapuntzakis M, Langenberg P, Kiani R, Lucchesi D, Sugerman SNormal serum response to oral beta-carotene in humansJ Am Coll Nutr.(1989 Dec)
14.^Junghans A, Sies H, Stahl WMacular pigments lutein and zeaxanthin as blue light filters studied in liposomesArch Biochem Biophys.(2001 Jul 15)
15.^la Cour M, Kiilgaard JF, Nissen MHAge-related macular degeneration: epidemiology and optimal treatmentDrugs Aging.(2002)
16.^Age-Related Eye Disease Study Research GroupA randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8Arch Ophthalmol.(2001 Oct)
17.^van Leeuwen R, Boekhoorn S, Vingerling JR, Witteman JC, Klaver CC, Hofman A, de Jong PTDietary intake of antioxidants and risk of age-related macular degenerationJAMA.(2005 Dec 28)
18.^Snellen EL, Verbeek AL, Van Den Hoogen GW, Cruysberg JR, Hoyng CBNeovascular age-related macular degeneration and its relationship to antioxidant intakeActa Ophthalmol Scand.(2002 Aug)
19.^[No authors listedRisk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study GroupArch Ophthalmol.(1992 Dec)
20.^Beatty S, Murray IJ, Henson DB, Carden D, Koh H, Boulton MEMacular pigment and risk for age-related macular degeneration in subjects from a Northern European populationInvest Ophthalmol Vis Sci.(2001 Feb)
Primary Use
Eyes & Vision